Non-absorbable disaccharides and antibacterials are the treatment of choice for hepatic encephalopathy

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.6, 2011-06, pp. : 17-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of the Treatment of Infectious Diarrhoea with Non-Absorbable Rifamycin SV Formulated as MMX Modified Release Tablet vs. Rifaximin

By Stefano A.F.D. Di   Binelli D.   Labuschagne W.   Mojapelo M.   Walt E. van der   Patel S.   Moro L.  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 192-203

Bentham Science Publishers

Access to resources Recommend Favorite

Efficacy of the Treatment of Infectious Diarrhoea with Non-Absorbable Rifamycin SV Formulated as MMX Modified Release Tablet vs. Rifaximin

By  

Anti-Infective Agents, Vol. 11, Iss. 2, 2013-07 ,pp. : 192-203

Bentham Science Publishers

Access to resources Recommend Favorite

Hepatic encephalopathy treatment guidelines

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 326, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Hepatic encephalopathy treatment guidelines

By  

Inpharma, Vol. 1, Iss. 1301, 2001-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Flumazenil is effective in the treatment of acute hepatic encephalopathy

By  

Inpharma, Vol. 1, Iss. 1338, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite